The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Respiratory Medicine

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rmed.2014.08.006PMID 25192601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)

  2014cited by this paper
• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

  2014cited by this paper
• C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.

  2013cited by this paper
• Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control

  2013cited by this paper
• Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.

  2013cited by this paper
• Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases

  2013cited by this paper
• [Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines].

  2012cited by this paper
• Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: A nested cohort study

  2012cited by this paper
• Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes

  2012cited by this paper
• Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD.

  2011cited by this paper
• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Incidence and Risk Factors of Steroid-induced Diabetes in Patients with Respiratory Disease

  2011cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.

  2006cited by this paper
• Impact of degree of obesity on surrogate estimates of insulin resistance.

  2004cited by this paper
• The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2002cited by this paper
• Adverse effects of corticosteroids.

  1998cited by this paper
• Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients

  1997cited by this paper
• Adverse effects of corticosteroids: II. Systemic.

  1986cited by this paper
• Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration.

  1975cited by this paper

• Glucocorticoid-Induced Hyperglycemia in Patients with Cancer: Mechanisms, Clinical Implications, and Management Strategies.

  2026cites this paper
• Potential Causal Relationship Between Chronic Obstructive Pulmonary Disease and Diabetes: A Bidirectional Two-Sample Mendelian Randomization Study

  2025cites this paper
• Abordaje integral de las comorbilidades en la EPOC: recomendaciones de expertos

  2025cites this paper
• Glucocorticoid treatment and new‐onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta‐analysis

  2024cites this paper
• Association between glycated haemoglobin and the risk of chronic obstructive pulmonary disease: A prospective cohort study in UK biobank

  2023cites this paper
• Factors Associated With Discordant A1C-Estimated and Measured Average Glucose Among Hospitalized Patients With Diabetes.

  2022cites this paper
• Variation in the hemoglobin glycation index.

  2022cites this paper
• Prevalence and associated factors of dysglycemia among patients with chronic obstructive pulmonary disease

  2021cites this paper
• Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry

  2021cites this paper
• Pitfalls of intermittent continuous glucose monitoring in patients with steroid diabetes.

  2021cites this paper
• Diabetic lung disease: fact or fiction?

  2019cites this paper
• glycated hemoglobin a 1 c-based adjusted glycemic variables in patients with diabetes presenting with acute exacerbation of chronic obstructive pulmonary disease

  2017cites this paper
• Glycated hemoglobin A1c-based adjusted glycemic variables in patients with diabetes presenting with acute exacerbation of chronic obstructive pulmonary disease

  2017cites this paper
• Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.

  2016cites this paper
• A comparative outcome analysis of incisional hernia repair in patients who underwent liver transplantation vs. those that underwent hepatopancreaticobiliary surgery using the EHS guidelines as a means of comparison

  2016cites this paper
• Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature

  2015cites this paper